dc.contributor.author | Ozkan, Fuat | |
dc.contributor.author | Peynircioglu, Bora | |
dc.contributor.author | Cil, Barbaros E. | |
dc.contributor.author | Yurttutan, Nursel | |
dc.contributor.author | Yalcin, Suayib | |
dc.contributor.author | Balkanci, Ferhun | |
dc.date.accessioned | 2019-12-10T11:31:59Z | |
dc.date.available | 2019-12-10T11:31:59Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 1306-133X | |
dc.identifier.uri | https://doi.org/10.4999/uhod.12038 | |
dc.identifier.uri | http://hdl.handle.net/11655/15981 | |
dc.description.abstract | The aim of this study was to present our single center experience with short (< 3 months) and intermediate-term (> 3 months) follow-up results of patients who underwent transarterial radioembolization with yttrium-90 microsphere (Y-90) or transarterial chemoembolization (TACE) for hepatic metastasis of neuroendocrine tumors (hmNETs). The results of 14 patients treated with either Y-90 or TACE were reviewed retrospectively. Clinical, laboratory, and imaging follow-up was performed. Efficacy was assessed by clinical and morphologic response. Survival was estimated by Kaplan-Meier analysis. Eight patients receiving 12 TACE treatments and 6 patients receiving 7 Y-90 treatments. Response rates were similar with two treatments at short-term follow-up, but there were a lower response rate and higher being progressive disease in the TACE group than Y-90 group at intermediate-term follow-up. However, progression-free survival was lower in Y-90 group (7.5 months) than TACE group (18 months). Regarding our limited experience, both Y-90 treatment and TACE have advantages and disadvantages in treatment of patients with hmNETs, however, randomized controlled studies, are needed. | |
dc.language.iso | en | |
dc.publisher | Akad Doktorlar Yayınevi | |
dc.relation.isversionof | 10.4999/uhod.12038 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Oncology | |
dc.title | Transarterial Chemo And Radioembolization (Yttrium90) Of Hepatic Metastasis Of Neuroendocrine Tumors: Single Center Experience | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.relation.journal | Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi | |
dc.contributor.department | Radyoloji | |
dc.identifier.volume | 23 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 20 | |
dc.identifier.endpage | + | |
dc.description.index | WoS | |
dc.description.index | Scopus | |